Pyoderma gangrenosum associated with regional enteritis. Improvement in defective granulocyte function and healing of skin lesions during administration of clofazimine.

A defective uptake of oxygen by peripheral blood granulocytes during phagocytosis, indicating a subnormal phagocytic capacity, has been found in a patient with regional enteritis complicated by pyoderma gangrenosum (PG). During administration of clofazimine and granulocyte function normalized and the skin lesions healed. It is possible that a defective granulocyte function may sometimes be involved in the pathogenesis of PG and that a clofazimine-induced improvement in the function will favour healing of the lesions. The result of treatment in our patient and in other cases recently published indicates that the drug may be worth trying in PG.

[1]  H. Odeberg,et al.  Granulocyte function in chronic granulocytic leukemia. II. Bactericidal capacity, phagocytic rate, oxygen consumption, and granule protein composition in isolated granulocytes. , 1976, Blood.

[2]  G. Michaëlsson,et al.  Clofazimine. A new agent for the treatment of pyoderma gangrenosum. , 1976, Archives of dermatology.

[3]  D. Rosenthal,et al.  Pyoderma Gangrenosum and rheumatoid arthritis. , 1975, Archives of dermatology.

[4]  Dantzig Pi.  Letter: Pyoderma gangrenosum. , 1975 .

[5]  L. Molin.  Clofazimine-enhanced phagocytosis in pustulosis palmaris et plantaris. , 1975, Acta dermato-venereologica.

[6]  B. Svensson,et al.  Stimulation of macrophage phagocytosis by clofazimine. , 2009, Scandinavian journal of haematology.

[7]  Bullock We,et al.  A statistical approach to the polymorphonuclear leukocyte bactericidal assay. , 1973 .

[8]  G. Achten,et al.  PYODERMA GANGRENOSUM WITH ALTERED CELLULAR IMMUNITY AND DERMONECROTIC FACTOR * , 1972, The British journal of dermatology.

[9]  L. Brandt.  Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function. , 2009, Scandinavian journal of haematology.

[10]  J. Cream.  PYODERMA GANGRENOSUM WITH A MONOCLONAL IgM RED CELL AGGLOMERATING FACTOR , 1971, The British journal of dermatology.

[11]  M. Cline.  Drug Potentiation of Macrophage Function , 1970, Infection and immunity.

[12]  Vischer Wa.  The experimental properties of G 30 320 (B 663)--a new anti-leprotic agent. , 1969 .

[13]  P. Kinmont,et al.  DERMATOLOGICAL MANIFESTATIONS OF CROHN'S DISEASE * , 1968, The British journal of dermatology.

[14]  G. Stathers,et al.  Pyoderma gangrenosum in association with regional enteritis. , 1967, Archives of dermatology.

[15]  Bishopric Ga,et al.  PYODERMA GANGRENOSUM AS THE PRESENTING SIGN OF REGIONAL ILEITIS: OBSERVATIONS REGARDING THE PATHOGENESIS OF THE SKIN LESIONS. , 1964 .

[16]  N. Karltorp.  Pyoderma gangraenosum with and without hypogammaglobulinemia. , 1963, Acta dermato-venereologica.